US Covid-19 data (July 6) update: US cases rise 2.0% v 7-day avg. 1.8%
|US Covid-19 data has been compiled for July 6 with US cases rising 2.0% v a 7-day average of 1.8%.
The following are a latest update of the key developments across the critical states for which are suffering the most:
- Texas Cases Rise 2.7% v 7-Day Avg. 4.0%.
- Texas Hospitalizations Rise 517 To Record 8,698.
- Florida Cases Rise 3.2% v 7-Day Avg. 5.1%.
- Arizona Cases Rise 3.4% v 7-Day Avg 4.1%
- California Cases Rise By Record 11,529.
US cases had been continuing to rise over the weekend, with the total number of cases nearing 2.9 million and deaths closing in on 130,000 reported yesterday.
The transmission rate in New Jersey rising to the highest level in 10 weeks
US COVID-19 storm clouds, transmission rate on the rise, concerns over airborne spread
The latest updates come from the transmission rate in the US state of New Jersey rising to the highest level in 10 weeks.
"I see storm clouds on the horizon," Gov. Andrew Cuomo said last Wednesday as he announced indoor dining New York City was postponed indefinitely.
Today, he warned that "this is a warning sign".
Market implications
Wall Street Close: US stocks surge and Nasdaq powers to record high
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.